BJDX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Bluejay Diagnostics Inc (BJDX) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The financial performance is weak, with declining net income and EPS, no significant trading trends, and no positive news or catalysts to support a bullish outlook. Additionally, the technical indicators and trading signals do not suggest a strong entry point.
The MACD is slightly positive, indicating mild bullish momentum, but RSI is neutral at 52.926, showing no clear trend. Moving averages are converging, suggesting indecision in the market. The stock is trading below the pivot level of 1.941, with key support at 1.81 and resistance at 2.072. Overall, the technical indicators do not suggest a strong buy signal.
NULL. There are no recent news events, insider trading, or hedge fund activity to act as positive catalysts.
The stock has a high probability of declining in the next month (-7.79%). Financial performance is weak, with significant declines in net income (-90.24% YoY) and EPS (-61.96% YoY). Post-market price dropped by -5.58%, indicating bearish sentiment.
In Q4 2025, revenue remained at 0 with no growth. Net income dropped significantly to -$1,429,812 (-90.24% YoY), and EPS declined to -42.32 (-61.96% YoY). Gross margin also remained at 0, showing no improvement.
No analyst rating or price target changes available. Wall Street sentiment appears neutral, with no strong pros or cons view on the stock.
